Convergent Therapeutics

Oncology

Dr Philip Kantoff, a world-renowned prostate cancer clinician and researcher, discusses alpha radiopharma treatment possibilities.

Patients

Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.